Evidence map›Paper›PMID 26146610›Full record

ArticleThe journal of prevention of Alzheimer's disease2014

Dementia Prevention: optimizing the use of observational data for personal, clinical, and public health decision-making.

Penny A Dacks, Sandrine Andrieu, Deborah Blacker, Aaron J Carman, Allan M Green, Francine Grodstein, Victor W Henderson, Bryan D James, Rachel F Lane, Joseph Lau and 9 more

Abstract read
In one paragraph

Article in The journal of prevention of Alzheimer's disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Brain Health and Dementia Prevention: A Mixed-method Analysis.American journal of health behavior · 2019
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Penny A DacksAlzheimer's Drug Discovery Foundation, New York, NY.
Sandrine AndrieuUMR 1027 INSERM-University Toulouse III, CHU Toulouse, Toulouse, France.
Deborah BlackerGerontology Research Unit, Department of Psychiatry, Massachusetts General Hospital/Harvard Medical School, and Department of Epidemiology, Harvard School of Public Health, Boston, MA.
Aaron J CarmanAlzheimer's Drug Discovery Foundation, New York, NY.
Allan M GreenMD PhD JD, Attorney at Law, Cambridge, MA.
Francine GrodsteinChanning Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Victor W HendersonDepartment of Health Research & Policy (Epidemiology); Department of Neurology & Neurological Sciences, Stanford University, Stanford, CA.
Bryan D JamesRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL.
Rachel F LaneAlzheimer's Drug Discovery Foundation, New York, NY.
Joseph LauCenter for Evidence-based Medicine, School of Public Health, Brown University, Providence, RI.
Pei-Jung LinCenter for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA.
Barnaby C ReevesClinical Trials and Evaluation Unit, School of Clinical Sciences, University of Bristol, UK.
Raj C ShahRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL.
Bruno VellasUMR 1027 INSERM-University Toulouse III, CHU Toulouse, Toulouse, France.
Kristine YaffeSchool of Medicine, University of California San Francisco, San Francisco, CA.
Karin Yurko-MauroDSM Nutritional Products.
Diana W ShinemanAlzheimer's Drug Discovery Foundation, New York, NY.
David A BennettRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL.
Howard M FillitAlzheimer's Drug Discovery Foundation, New York, NY.

Funding

SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BARNES, LISA L · 1991 to 2020
$49.1M
THE ROLE OF ADVANCED CAA IN ALZHEIMER'S DEMENTIAP50AG005134 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI HYMAN, BRADLEY T. · 1985 to 2018
$42.1M
Predictors & Outcomes of Cognitive Trajectories in the Oldest OldK24AG031155 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI YAFFE, KRISTINE · 2007 to 2020
$1.5M
NIA NIH HHS K24 AG031155NIA NIH HHS P30 AG010161NIA NIH HHS P50 AG005134
6 · The paper itself

Abstract

Worldwide, over 35 million people suffer from Alzheimer's disease and related dementias. This number is expected to triple over the next 40 years. How can we improve the evidence supporting strategies to reduce the rate of dementia in future generations? The risk of dementia is likely influenced by modifiable factors such as exercise, cognitive activity, and the clinical management of diabetes and hypertension. However, the quality of evidence is limited and it remains unclear whether specific interventions to reduce these modifiable risk factors can, in turn, reduce the risk of dementia. Although randomized controlled trials are the gold-standard for causality, the majority of evidence for long-term dementia prevention derives from, and will likely continue to derive from, observational studies. Although observational research has some unavoidable limitations, its utility for dementia prevention might be improved by, for example, better distinction between confirmatory and exploratory research, higher reporting standards, investment in effectiveness research enabled by increased data-pooling, and standardized exposure and outcome measures. Informed decision-making by the general public on low-risk health choices that could have broad potential benefits could be enabled by internet-based tools and decision-aids to communicate the evidence, its quality, and the estimated magnitude of effect.

Indexed as

Alzheimer’scommunicationlow-risknon-randomized studiesprimary prevention

Identifiers

PMID26146610
PMCPMC4487813

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.